Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States by Rutika Mehta, Astra M. Liepa, Shen Zheng, Anindya Chatterjee

Subjects: Get full text

A Multicenter Study on the Challenges and Real-World Utilization of Immune Checkpoint Inhibitors in Resource-Constrained Settings: Insights and Implications from India by Ashwin Oommen Philips, Sunu Cyriac, P. Unnikrishnan, Anil T. Jose, Krishnakumar Rathnam, S.V. Saju, Smita Kayal, Soumya Surath Panda, Lalatendu Moharana, Sindhu Kilaru, Amit Sehrawat, Deepak Sundriyal, Puneet Dhamija, Deepak Jain, Pamela Alice K., Jaineet Sachdeva, Nishant Batta, Raman Arora, Yogesh Arora, Harpreet Singh, Mridul Anand, Ishu Sharma, Prasanth Ganesan

Subjects: “…biomarker testing…”
Get full text

The Importance of Biomarker Testing in the Treatment of Advanced Non-Small Cell Lung Cancer: A Podcast by Fred R. Hirsch, Chul Kim

Subjects: Get full text

Trends of Molecular Testing for Lung Cancer at the King Faisal Hospital, Kigali: Therapeutic and Survival Implications by Achille Van Christ Manirakiza, MD, Fidel Rubagumya, MD, Eulade Rugengamanzi, MD, Alphonsine Mukandekezi, MD, Jessica Beneyo, BMLS, Maurice Musoni, MD, Thierry Zawadi Muvunyi, MD

Subjects: Get full text

Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction by Michał Węgiel, Tomasz Rakowski

Subjects: Get full text

Barriers to mutational testing in patients with gastrointestinal stromal tumors (GIST) – a survey of life raft group members by Denisse Montoya, Jerry W. Call, Jennily Eshak, Pete Knox, Maeven Luedke, Sahibjeet Kaur, Sara Rothschild, Mary Garland, Norman J. Scherzer

Subjects: Get full text

Diagnosis, testing, treatment, and outcomes among patients with advanced non‐small cell lung cancer in the United States by Mo Yang, Joanna P. MacEwan, Sai Sriteja Boppudi, Monica R. McClain, Richard M. O'Hara Jr, Paul K. Paik

Subjects: Get full text

Optimizing molecular testing of lung cancer needle biopsy specimens: potential solutions from an interdisciplinary qualitative study by Florian J. Fintelmann, Nikki A. Martin, Ismail Tahir, Elissa M. Quinn, Timothy C. Allen, Lija Joseph, Boris Nikolic, Christopher Lee

Subjects: Get full text

Biomarker and Companion Diagnostics—A Review of Medicinal Products Approved by the European Medicines Agency by Laura Patricia Orellana García, Laura Patricia Orellana García, Falk Ehmann, Philip A. Hines, Philip A. Hines, Philip A. Hines, Armin Ritzhaupt, Angela Brand

Subjects: Get full text

Racial and ethnic differences in older adults’ willingness to be contacted about Alzheimer's disease research participation by Christian R. Salazar, Dan Hoang, Daniel L. Gillen, Joshua D. Grill

Subjects: Get full text

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021 by Lisa M. Hess, PhD, Peter M. Krein, PhD, Diane Haldane, MS, Yimei Han, MS, Anthony N. Sireci, MD

Subjects: “…Biomarker testing…”
Get full text

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan by Yasushi Yatabe, MD, PhD, Yasumasa Yoshiki, MPH, Koichi Matsumura, PhD, Kanae Togo, MSc, Hironori Kikkawa, PhD, Laura Iadeluca, PhD, MPH, Benjamin Li, PhD, Kazuto Nishio, MD, PhD

Subjects: Get full text

Clinical use of [TIMP-2]•[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel by Louis M. Guzzi, Tobias Bergler, Brian Binnall, Daniel T. Engelman, Lui Forni, Michael J. Germain, Eric Gluck, Ivan Göcze, Michael Joannidis, Jay L. Koyner, V. Seenu Reddy, Thomas Rimmelé, Claudio Ronco, Julien Textoris, Alexander Zarbock, John A. Kellum

Subjects: “…Biomarker testing…”
Get full text

Biomarker Testing, Targeted Therapy and Clinical Trial Participation by Race Among Patients With Lung Cancer: A Real-World Medicaid Database Study by Debora S. Bruno, MD, MS, Xiaohong Li, MPH, Lisa M. Hess, PhD

Subjects: “…Biomarker testing…”
Get full text

Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine by Liza C. Villaruz, Mark A. Socinski, Jared Weiss

Subjects: Get full text

Real-World Management and Outcomes of Crizotinib-Treated ROS1-Rearranged NSCLC: A Retrospective Canadian Cohort by Amanda J. W. Gibson, Adrian Box, Winson Y. Cheung, Michelle L. Dean, Anifat A. Elegbede, Desiree Hao, Aliyah Pabani, Randeep Sangha, Dafydd Gwyn Bebb

Subjects: Get full text

NSCLC in the Era of Targeted and Immunotherapy: What Every Pulmonologist Must Know by Carley L. Mitchell, Annie L. Zhang, Debora S. Bruno, Francisco A. Almeida

Subjects: Get full text

Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada by Stephanie Snow, Christine Brezden-Masley, Michael D. Carter, Neesha Dhani, Cassandra Macaulay, Ravi Ramjeesingh, Michael J. Raphael, Monika Slovinec D’Angelo, Filomena Servidio-Italiano

Subjects: Get full text

Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational stud... by Urpo Kiiskinen, Grace Segall, Hollie Bailey, Cameron Forshaw, Tarun Puri

Subjects: Get full text

Assessing the role of Chemokine (C–C motif) ligand 14 in AKI: a European consensus meeting by Jay L. Koyner, Christian Arndt, Jaume Baldira Martinez de Irujo, Sílvia Coelho, Manuel Garcia-Montesinos de la Peña, Luca di Girolamo, Michael Joannidis, Pablo Jorge-Monjas, Christian Koch, Steven Lobaz, Alain Meyer, Marlies Ostermann, Nicoletta Pertica, John R. Prowle, Jon Silversides, Alexander Zarbock, Jorge Echeverri, Kai Harenski, Lui G. Forni

Subjects: “…Biomarker testing experience…”
Get full text